4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-23-000870
Director acquired 17,501 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Coleman Mark · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-03 | Exercise or conversion : show line 1 in the form | +17,501 | $1.30 | $22,751 | 25,097 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-03 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −17,501 | 0 | D |
Loading xslF345X03/doc4.xml…